Ticker Details
NewAmsterdam Pharma Company
IPO Date:	February 9, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.33B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.65 | 3.18%
Avg Daily Range (30 D):	$0.81 | 2.64%
Avg Daily Range (90 D):	$0.93 | 2.87%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	.91M
Avg Daily Volume (90 D):	1.06M

Trade Size
Avg Trade Size (Sh.):	85
Avg Trade Size (Sh.) (30 D):	69
Avg Trade Size (Sh.) (90 D):	75

Institutional Trades
Total Institutional Trades:	1,517
Avg Institutional Trade:	$1.71M
Avg Institutional Trade (30 D):	$1.83M
Avg Institutional Trade (90 D):	$2.21M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$1.93M
Avg Closing Trade (30 D):	$2.75M
Avg Closing Trade (90 D):	$2.8M
Avg Closing Volume:	67.95K

News

Jun 3, 2026 @ 12:00 PM NewAmsterdam Pharma Announces Upcoming Presentatio... Source: Newamsterdam Pharma Company N.V.

May 28, 2026 @ 12:00 PM NewAmsterdam Pharma to Participate at Upcoming Inv... Source: Newamsterdam Pharma Company N.V.

May 1, 2026 @ 8:57 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: Na

Apr 2, 2026 @ 9:43 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: Newamsterdam Pharma Company N.V.

Feb 4, 2026 @ 1:00 PM NewAmsterdam Pharma to Present at the Guggenheim E... Source: Newamsterdam Pharma Company N.V.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-2.16	$-.52	$-.4
Diluted EPS	$-2.16	$-.52	$-.4
Revenue	$7.12M	$3.7M	$3.04M
Gross Profit
Net Income / Loss	$-259.5M	$-64.14M	$-48.44M
Operating Income / Loss	$-244.41M	$-64.86M	$-58.42M
Cost of Revenue
Net Cash Flow	$-136.69M	$-32.94M	$-31.05M
PE Ratio